Trial Profile
A retrospective cohort study of Entyvio (vedolizumab) in biologic-naive adults with ulcerative colitis and Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 15 Oct 2018 New trial record
- 08 Oct 2018 According to a Takeda media release, data were presented at ACG 2018.
- 08 Oct 2018 Results published in the Takeda Media Release